
Dr. Theodore Jardetzky
Stanford UniversityTargeting EBV Entry Glycoproteins for Vaccine and Therapeutic Development

International collaborations play an important role in building a more connected and globally engaged scientific community committed to shaping the future of MS. Through knowledge sharing and high-impact partnerships that transcend borders, we can accelerate breakthroughs that redefine how MS is understood, diagnosed, and managed—ultimately unlocking lasting solutions for the global MS community.
Targeting EBV Entry Glycoproteins for Vaccine and Therapeutic Development
Learn more about our research strategy and how you can contribute to advancing Multiple Sclerosis research.